AUThOR INDEX

April 15, 1994

Agarwal, C., 2108

Albelda, S. M., 2055Ambrose, D., 2218Amin, K. M., 2055Anderson, K. C., 2234

Andersson, K. B., 2245Andrews, J. C., 2121Antoine, N., 2073Antoku, S., 2088Appel, M. J., 2113

Baserga, R., 2218Baylin, S. B., 2098Behrens, C. H., 2199Behrens, D. L, 2199Bénard,I., 2256Bevilacqua, P., 2251Blaese, R. M., 2141Blomhoff, H. K, 2245Bohlander, S. IC, 2060Bold, R. J.,2129

Bonilla, M. A., 2228Bosslet, K., 2151Brem, H., 2207Bull, J. M. C., 2223Burger, P. C., 2207

Cuban, M. A., 2207Calabretta, B., 2251Canete,A., 2228

Castello, M. A., 2251Castronovo, V., 2073Chauhan, D., 2234Chen, S-F., 2199Chen, Y-L., 2192Cheung, I. Y., 2228Cheung, N-K. V., 2228Chiang, Y., 2141Christoffersen, J., 2245Colvin, 0. M., 2207Coppes, M. J., 2077Coppola,D., 2218Croce, C. M., 2095Czech, J., 2151

Danhauser,L L, 2223Da Silva, J., 2256Davidson, B. L., 2055Daya-Makin,M., 2262Dc Roanne, C., 2073Dedrick, R. L, 2166del Mar Alonso, M., 2084Dexter, D., 2199Domb, A., 2207Dominici, C., 2251Dreyling, M., 2060Dvorak, H. F., 2269

Eck, S. L, 2055Eckert, R. L, 2108Ensminger, W. D., 2121

Felsani, A., 2251Ferrandis, E., 2256

Ferrando, A. A., 2091Fodstad, 0., 2146Fontasubre, B., 2064Frébourg,T., 2064Fredericks, J. R., 2199Freije, J. M. P., 2091FroSCM, G., 2064

Gabrielson, E., 2098Godal, A., 2146Greimers, R., 2073Gross, J. L, 2199Guo, J. W. H., 2186Gur, A., 2207

Hakomori, S-i., 2213Haldar, S., 2095Heinen, E., 2073Heller,G., 2228Hembree, J. R., 2108Hermonat, P. L., 2278Herndier, B. G., 2069Heya, T., 2160Hilton, J., 2207Hoffmann,D.,2151Hogg, J. C., 2262Hong, K., 2186Huang,A., 2186Huang,S. K., 2186Hunt, J., 2084Hwang, H. C., 2055

Igarashi, Y., 2213Ishizuka, J., 2129

Jenkins, 0. N., 2223Jeong, J. M., 2160

Kaiser, L R., 2055Kaneko, T., 2223Kawa, S., 2213Kharbanda, S. M., 2234Kim, S. S., 2240Kirshenbaum, M. R., 2199Knol, J.A., 2121

Kodama,T., 2136Kufe, D. W., 2234Kusaka, M., 2073Kushner, B., 2228

Larson, S. M., 2228Lawrence, T. S.,2121

12, N., 2160Lee, J. T., 2160Lee, Y. H., 2240Lehmann, M., 2102Un, K., 2269Lipp, M., 2262Ussitzky, J-C., 2102López-Otmn,C., 2091

Mabry,M.,2098Makino, M., 2223Malkin, D., 2077

Martinez, J., 2129Marvaldi, J., 2102McGrath, M. S., 2069Merlo, A., 2098Michot, J. P., 2064Miller, A. A., 2080Miyake, Y., 2136Mogentale, T. L., 2262Monne, M.,2095Morel, A. P., 2064Mueller, S. N., 2141Muindi, J. F., 2125Myklebust, A. T., 2146

Nagy, J. A., 2269Nakamura, K., 2088Negrini, M., 2095Negroni, A., 2251Neumann, R. D., 2160, 2166Noh, D-Y., 2240

Oberhammer, F., 2064Oldfield, E. H., 2141Olopade, 0. I., 2060Oshiro, E. M., 2141Ozturk, M., 2064

Paik,C. H.,2160

Papahadjopoulos, D., 2186Papp, L M., 2199Parchomchuk, J., 2262Park, J-G., 2240Park, K. J., 2240Park, Y. S., 2213Patten,A. D.,2199Pelech, S. L., 2262Phillips, T. L., 2186Pichon, J., 2102Polkus, S. T., 2199Ponchel, F., 2064Pucci, S., 2251Puisieux, A., 2064

Quaranta, V., 2102

Rabenandrasana, C., 2102Ram, Z., 2141Raschella, G., 2251Resnicoff, M., 2218Rigas, J. R., 2125Riou, G., 2256

Rodriguez, M., 2129Romeo, A., 2251Rorke, E. A, 2108Roulston, D., 2060Ruan, F.,2213

Rubin, R., 2218Rubini,M.,2218Rukstalis, D., 2060Ryu, S. H., 2240

Sabbioni, S., 2095Saga, T., 2160, 2166Sakaguchi, Y., 2223

Sanghera, J. S., 2262Scher, H. I., 2125Seitz, S. P., 2199

Sell, C., 2218Sexsmith, E., 2077Sherman, J., 2060Shiramizu, B., 2069Shockley, T. R., 2269Shridhar, V., 2084Sidransky, D., 2098Siegfried, J., 2084Simar, L. J., 2073Sipple, P., 2199Sladek, N. E., 2176Smeland, E. B., 2245Smith, D. I., 2084Smythe, W. R., 2055Sreerama, L., 2176Stadler, W. M., 2060Stafford, M. M., 2199Stauffer, P. R., 2186Stephens, L. C., 2223Stetson, P. L., 2121Stokke, T., 2245Strebel, F. R., 2223Suh, P-G., 2240Sukhatme, V. P., 2234Sun, J-H., 2199Sung, C., 2160, 2166

Tabone, E., 2064Tamura,R.,2102Taskén,K.,2245Thompson, J. C., 2129Tolley, E. A., 2080Townsend, C. M., Jr., 2129Tyler, B., 2207

Uchiyama, H., 2234Urla, J. A., 2091

van Garderen-Hoetmer, A., 2113van Osdol, W. W., 2166Velasco, G., 2091Viola, J. J., 2141Vollmer, R., 2098

Wagner,J.G.,2121Walbridge, S., 2141Walker, S. C., 2121Walter, K. A., 2207Warrell,R. P., Jr., 2125Weinstein, J. N., 2160, 2166Williams, B. R. G., 2077Wilson, J. M., 2055Woutersen, R. A., 2113Wu, R-T., 2192

Xu, H., 2269

Yamaguchi, K., 2136Yarmush, M. L., 2269Yeger, H., 2077Yeh, S. J., 2228Young, C. W., 2125

2285

Notification of Candidate

GUIDELINES FOR APPLICATION FOR ACTIVE ANDCORRESPONDING MEMBERSHIP

BENEFITS OF MEMBERSHIPA complete application consists of the following material:1. 6 copies of the form on the opposite side of this page, with all

requested information provided.2. 5 copiesof the candidate's most current curriculum vitae and

bibliography.3. 5 copiesof a letter of recommendationfrom a nominator who is

an active, corresponding, emeritus, or honorary member of theAACR (at least one copy must be a signed, original letter). Thisletter should describe the candidate's achievements in laboratoryresearch, clinical investigations, orepidemiological research, andit should affirm that this research adheres to accepted ethicalscientific standards. —OR—The nominator may supply theresponses requested at the bottom ofthe application form in thesection entitled “STATEMENT OF SUPPORT― (at least one copyof the form must be the signed original).

4. 5 copies of a letter of recommendation as described in Item 3above from a seconder who is an active, corresponding, emeritus,or honorary member of the AACR (at least one copy must be asigned, original letter). —OR—The seconder may supply theresponses requested at the bottom of the application form in thesection entitled ‘STATEMENTOF SUPPORT―(at least one copyof the form must be the signed original).

5. 5 reprints of each of two publications on which the candidateappears as author.All material should be collated into five complete sets with the

original application form as a covering document and sent to theaddress given below. Questions regarding procedures for membership application may also be directed to the following address:

American Association for Cancer ResearchPublic Ledger Building

620 Chestnut StreetSuite 816

Philadelphia, PA 19106-3483Phone: 215/440-9300FAX: 215-440-9313

RESPONSIBILITIES OF MEMBERSHIP

Candidates should be aware of the following responsibilities ofmembership in the AACR. Active members must pay annual dues,a major portion of which is designated for subscriptions to AACRpublications. In 1994 dues for active members are $150, $95 ofwhich is designated for journal subscriptions. Newly electedmembers of the AACR who have already purchased subscriptionsto Cancer Research, Cell Growth & Differentiation, or CancerEpidemiology, Biomarkers & Prevention at the higher, nonmemberrate will receive reimbursement of the unused portion of thosesubscriptions once their first year's membership dues are paid infull.

Corresponding members are required to pay dues ($65 in 1994)and may, if they wish, subscribe to Cancer Research, Cell Growth& Differentiation,or Cancer Epidemiology, Biomarkers & Preven

tion at reduced member rates.Applicants elected in March will be responsible for payment of

that year's dues; applicants elected in July and November will paydues for the following year. Applicants elected in March and Julywill be eligible to sponsor an abstract for the next annual meeting.Every effort will be made to afford the same opportunity toapplicants elected in November.

Margaret FotiExecutive Director

The American Association for Cancer Research (AACR), ascientific society consisting of laboratory and clinical cancerresearchers, was founded in 1907 to facilitate communication anddissemination of knowledge among scientists and others dedicatedto the cancer problem; to foster research in cancer and relatedbiomedical sciences; to encourage the presentation and discussionof new and important observations in the field; to foster publiceducation, science education, and training; and to advance theunderstanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world.

Members of the AACR enjoy the following benefits:

1. subscriptions to all of the Association's high-quality journals,Cancer Research, Cell Growth & Differentiation, and CancerEpidemiology, Biomarkers & Prevention , at reduced memberrates;

2. the privilege of sponsoringa paper for presentationat the AACRannual meeting;

3. an advance copyof the scientific Program and the Proceedingsofthe American Association for Cancer Research for each annualmeeting;

4. reduced registration rates at all scientific meetings;5. priority notification of events in the AACR's outstanding series

of special conferences on timely subjects in the field;6. the receipt of AACR newsletters, meeting announcements,and

an up-to-date membership directory;7. reduced rates for the AACR Employment Register; and8. the professional benefits of AACR's public education activities.

QUALIFICATIONS FOR MEMBERSHIPActive membership in the AACR is open to investigators who

live in the Americas. Individuals who have conducted two years ofresearch resulting in peer-reviewed publications relevant to cancer,or who have made substantial contributions to cancer research inan administrative or educational capacity, are eligible. If acandidate is working in a research area not directly related tocancer but has conducted research of merit in a related area ofbiomedical science, he or she may also qualify for membership.

Corresponding membership is open to persons who are notresidents of the Americas. The qualifications for correspondingmembership are the same as those for active membership. Visitingscientists from outside the Americas who intend to return to theircountries of origin by the anticipated time of election should applyfor corresponding membership. All other visiting scientists shouldapply for active membership and transfer to corresponding statusat a later date upon leaving the Americas. Graduate and medicalstudents, postdoctoral fellows, and physicians in training who donot yet meet the above qualifications should apply for associatemembership.

PROCEDURES FOR APPLICATION

There are three deadlines for receipt of a membership application: January 1, May 1, and September 1 of each year. TheMembership Committee will review all complete applications foractive membership that have been received by these deadlines andwill submit recommendations on each candidate to the Board ofDirectors which formally elects all members. The same procedureis followed by the Special Memberships Committee which receivesapplications for corresponding membership. Candidates will benotified according to the following schedule:

Receipt of Application

in AACR Office _______________January 1May 1September 1

MarchJulyNovember

AMERICANASSOCIATIONFORCANCERRESEARCH

(City) (State/Province)

TELEPHONE NUMBER:___________________________(Country)

(Postal Code)

FAXNUMBER:_________________________E-MAILNUMBER

PRIMARY FIELD OF RESEARCH (Please check only one):Biochemistry and Biophysics Biostatistics

.......Cellular Biology and Genetics Clinical Investigations

......Epidemiology ....jmmunologyPreclinical Pharmacology and Virology

Experimental Therapeutics(CARRIER):____________________________________Carcinogenesis

..............EndocrinologyMolecular Biology and Genetics

Other:_________________________________(Pleasespecify)ACADEMIC

DEGREES (Including where and whengranted)EXPERIENCE

SINCE HIGHEST DEGREE WAS GRANTED (Please Iist most recent first)

DATE OF BIRTH:_________NAME OF CANDIDATE:LAST FIRST M.I.

PRESENT POSITION/TITLE:_

INSTITUTIONAL AFFILIATION:

INSTITUTIONAL ADDRESS:

PUBLICATIONS (Reprints of two peer-reviewed articles on which the candidate appears as an author must accompany thisapplication. For these two articles list the authors, title, journal, volume, inclusive pages, and year. Do not submit abstracts.)

CANDIDATENOMINATED BY*:

CANDIDATESECONDED BY*:

0 CORRESPONDING

(Please print)

MEMBERSHIP

(Please print)

0 ACTIVECANDIDATE IS APPLYING FOR (Check one):

STATEMENT OF SUPPORT (in place of letters of recommendation)Instead of submitting letters of recommendation, either the nominator or the seconder or both may complete the following section:

How long has the candidate worked in the field of cancerresearch? @@yearsWill the candidate make a long-term contribution to cancerresearch? Yes NoDoes the candidate's research adhere to accepted ethicalstandards? Yes NoI therefore recommend this candidate for membership in theAmerican Association for Cancer Research.

How long has the candidate worked in the field of cancerresearch? @@yearsWill the candidate make a long-term contribution to cancerresearch? _Yes _NoDoes the candidate's research adhere to accepted ethicalstandards? Yes NoI therefore recommend this candidate for membership in theAmerican Association for Cancer Research.

Date DateSignature of nominator* Signature of seconder*

See Guidelines for Application on the reverse side of this form for further instructions.

*Both nominator and seconder must be active, corresponding, emeritus, or honorary members of the AACR.

(This form may be reproduced.)

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building - 620 Chestnut St. - Suite 816 . Philadelphia, PA 19106-3483

APPLICATION FOR ACTIVE OR CORRESPONDING MEMBERSHIP

@IDELINESFOR APPLICATION FOR ASSOCIATE MEMBERSHIP

signatures of both the candidate and the nominator. The application form may be submitted to the Association Office at any time.

After review of applications for associate membership, theExecutive Director will notify candidates of their election ordeferral within one month of the receipt of the application form.A check for one year's dues payment must accompany the application. Dues are currently $30 for associate members residing in theAmericas and $40 for residents of other countries. This fee will berefunded to any candidate deemed to be ineligible for associatemembership. Checks should be in U.S. currency, made payable toAACR, Inc., and drawn on a U.S. bank. Send the three copies ofthe application form and the $30 or $40 dues payment to:

American Association for Cancer ResearchPublic Ledger Building

620 Chestnut StreetSuite 816

Philadelphia, PA 19106-3483215/440-9300

RESPONSIBILITIES OF MEMBERSHIP

Associate members must pay annual dues in an amount to bedetermined by the AACR Board of Directors. Dues for 1993 and1994 have been set at $30 per year for residents of the Americasand $40 for residents of other countries. If an application issubmitted by August 31, the accompanying dues payment will becredited to the current year. Candidates submitting applicationsbetween September 1 and December 31 may indicate whether theywish their dues payments credited to the current or forthcomingyear. Candidates should be aware, however, that associatemembers may sponsor an abstract for the annual meeting only iftheir dues for the current year are paid. For example, an associatemember submitting an abstract in October 1993 for the forthcoming annual meeting must have paid dues for 1993. Any newlyelected associate members of the AACR who have already purchased subscriptions to Cancer Research, Cell Growth & Differentiation, and Cancer Epidemiology, Biomarkers & Prevention at thehigher, nonmember rate will receive a refund for the unusedportion of that subscription upon receipt of their payment for amember's subscription.

Each Fall the AACR will send to current associate members aninvoice for dues for the forthcoming year. Payment of this invoicemust be accompanied by a statement signed by the associatemember's current registrar, dean, or department head, verifyingthe member's current academic status. The Association's By-Lawsstate that dues are payable for each year in advance by January 1of the year to which they should be applied. An individual may bean associate member for a maximum of five years. Each year inwhich an individual pays dues will count as one full year ofassociate membership. Thus, an associate member who pays duesfor 1993 may retain associate membership until December 31,1997. The Board ofDirectors may terminate the membership of anassociate member whose dues are in arrears for two years.

Margaret FotiExecutive Director

AMERICAN ASSOCIATION FOR CANCER RESEARCH

QUALIFICATIONS FOR MEMBERSHIP

Associate membership is open to graduate students, medicalstudents, postdoctoral fellows, and physicians in training who arefollowing a course of study or who are working in a researchprogram relevant to cancer. Scientists in training who alreadyhave a substantial record of publications may wish to apply foractive or corresponding membership which confers full benefits ofmembership.

BENEFITS OF MEMBERSHIP

The American Association for Cancer Research (AACR), ascientific society consisting of laboratory and clinical cancerresearchers, was founded in 1907 to facilitate communication anddissemination ofknowledge among scientists and others dedicatedto the cancer problem; to foster research in cancer and relatedbiomedical sciences; to encourage presentation and discussion ofnew and important observations in the field; to foster publiceducation, science education, and training; and to advance theunderstanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world. Associate members of the AACRenjoy the following benefits:

1. the privilege ofsponsoring a paper for presentation at the AACRannual meeting provided that (a) the associate member is thepresenter of the paper and (b) an active, corresponding, emeritus, or honorary member in good standing of the AACR alsosigns the abstract of the paper in support of the work (In thisinstance, the member who cosigns the abstract does not lose hisor her own sponsorship privilege.);

2. an advance copy of the scientific Program and (if one has beenpurchased by the associate member) the Proceedings of theAmerican Association for Cancer Research which containsabstracts of all papers being presented at each annual meeting;

3. the privilege of registering for the annual meeting at the lowstudent rate (This rate is otherwise available only to predoctoralstudents.);

4. preferred access to the AACR Employment Register;@ 5. optional subscriptions to the Association's high-quality journals@ Cancer Research, Cell Growth & Differentiation, and Cancer

Epidemiology, Biomarkers & Prevention at reduced member@ rates;@ 6. priority notification of events in the AACR's series of special@ conferences on timely subjects in the field;@ 7. reduced registration rates at special conferences;@ 8. the receipt of AACR newsletters, meeting announcements, and@ an up-to-date membership directory; and@ 9. the facilitation of informal scientific exchange with leading@ researchers in the cancer field.

@ PROCEDURES FOR APPLICATION

@ Persons wishing to apply for associate membership must use the@ official application form on the reverse side of these instructions.@ Each candidate for associate membership must be nominated by an@ active, corresponding, emeritus, or honorary member in good@ standing of the AACR. Three completed copies of the form should@ be submitted; at least one of these copies must carry the original

PNAME OF CANDIDATE:_________________________________________ DATE OF BIRTH:_________

LAST FIRST M.I.

(City) (State/Province)

TELEPHONE NUMBER:__________________________

PRESENT ACADEMIC STATUSPFITLE (Please check only one):............Graduate Student Medical Student

Physician in Training Postdoctoral Fellow

PRIMARY FIELD OF RESEARCH (Please check only one):..............Biochemistry and Biophysics Biostatistics

Cellular Biology and Genetics Clinical Investigations..Epidemiology lmmunology

Preclinical Pharmacology and VirologyExperimental Therapeutics

(Country) (Postal Code)

- FAX NUMBER:___________________

E-MAIL NUMBER (CARRIER):________________

Carcinogenesis....Endocrinology

Molecular Biology and GeneticsOther:

(Please specify)

ACADEMIC DEGREES (Please indicate degree(s) acquired to date along with the name of the academic institution and date ofreceipt. Provide information on degree currently being sought and the anticipated date of completion of this degree program.)

RELEVANT RESEARCH EXPERIENCE NOT RELATED TO COURSE WORK (Please list most recent first.)

PUBLICATIONS (List the authors, title, journal, volume, inclusive pages, and year of any article in a peer-reviewed journal onwhich the candidate appears as an author. Do not list abstracts. Continue on a separate sheet, if necessary.)

CANDIDATE NOMINATED BY:(Pleasetype or print name ofAACR active member in good standing.)

SIGNATURESI hereby apply for associate membership in the American Association for Cancer Research. I have read the instructions on thereverse side of this form, and I understand the privileges and responsibilities of this class of membership. I certify that thestatements on this application are true.

Signature of Candidate: Date:

I recommend this candidate for associate membership in the American Association for Cancer Research. To the best of myknowledge, the candidate is qualified for this class of membership, and the statements on this application are true.

Signature of Nominator*: Date:

Submit three copies of this form. At least one copy must contain the original signatures of the candidate and the nominator.Enclose a check in U.S. funds, made payable to AACR, Inc. , and drawn on a U.S. bank for one year's dues. Dues are currently $30for associate members residing in the Americas and $40 for residents of other countries.

Check one of the following boxes only if this form is being submitted between September 1 and December 31:The enclosed dues payment should be applied to the 0 current 0 forthcoming calendar year.

(NOTE: Ifdues are applied to the forthcoming year, membership will take effect on January 1, but the candidate will not be eligibleto sponsor an abstract for presentation at the annual meeting in May of that year.) See Guidelines for Application on the reverseside of this form for further instructions.

*Nominator must be active, corresponding, emeritus, or honorary member of the AACR.

(This form may be reproduced.)

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building . 620 Chestnut St. . Suite 816 . Philadelphia, PA 19106-3483

INSTITUTIONAL AFFILIATION:

INSTITUTIONAL ADDRESS:

PLEASE FILL OUT ALL INFORMATION ON REVERSE SIDE AND SUBMIT THIS FORM WITH YOUR DISK.DISKS WILL NOT BE PROCESSEDWITHOUT THIS INFORMATION.

XyWnteIll Plus(for the IBM)WordPerfect4.2, 5.0, 5.1 (for the IBM)WordPerfect(fortheMac)Wordstar(fortheIBM)

Alsoacceptable:

AppleIIDOS3.3Applewith AppleworksSoftwareAppleIll PlusDOS3.3AppleMacIntosh400K Disc/

MacWrite2.2(text)AppleMacIntoshPlus800KDisc/

MacWrite 4.5 (text)cPT 8000DECWPS-.8DECDecmateIIDECDecmateIIIDisplay Write 3

Microsoft Word (for the IBM)MicrosoftWordMacintosh

(Versions 1—4)400/800KWangOIS(WPS)

Display Write 4IBMDisplaywriterWordProcessor6580LanierBusinessOneStepLanier No ProblemLanier Super No ProblemMASS-li PCMultimatePCWritePFSProfessionalWriteVolkswnter 4.0

New releases of word processing software are not always immediately available for conversion. In additiOn,because of the file structures and internal coding, we cannot accept disks created on desktop publishingsystemsor those created on proprietarytypesettingsystems.We also cannot guaranteethat all specialcharacterscanbetranslated.Tabularandmathematicalmaterial,suchasequations,willnotbecapturedfromthediskbutwillberekeyed.

To expeditework andfor your own security,we do requirethat you submita hardcopy printoutof the diskfile.Thetablesandequationswill be keyedfromthis hardcopy.Wealsoneedto knowthe nameof the file tobeconverted,the typeof hardware(e.g., IBMPC)on whichthefileswerecreated,theoperatingsystem(e.g.,DOS3.3),andtheversionof thesoftware(e.g.,WordPerfect5.1)usedtocreatethefile.

Guidelines for Submitting Disksto

American Association for Cancer Research Publications

Thewordprocessingpackagesthatwepreferareasfollows:

DISK SUBMISSION FORM

AACR joumals are now using personal computers to copyedit manuscripts accepted for publication. Whensubmittinga revisedmanuscript,authorsareencouragedto submitanelectronicdiskof thepaperalongwiththerequiredfourhardcopyprintouts.Diskswillultimatelyberetumedto theauthors.

I Seereverseforthewordprocessingpackagesthatcanbeaccepted.File preparation

Pleasebesurethatthefileyousendis themostrecentversionof themanuscriptandthat it matchesthemost recently submittedprinted copy. The file shouldcontain all the parts of the manuscriptin one file.Mathematicalandtabularmaterial,however,will be processedin the traditionalmannerandmaybeexdudedfromthediskfile.

Note:AACRdoesnot assumeresponsibilityfor errors in conversionof customizedsoftware,newlyreleasedsoftware,or specialcharacters.

Pleaselabel the outside of the disk with the joumal name, the first author's name,a partial title of themanuscript,andthenameof thecomputerfileusedto accessthemanuscriptondisk.Toprocessyourdiskefficiently,we needthe followinginformation.Pleasebesureto provideALL the information.

Nameusedto accesspaperondisk:Nameof computerused(e.g., IBM/PS2):Operatingsystem and version (e.g., DOS3.3):Wordprocessingprogramandversion(e.g.,WordPerfect5.0):

[See reverse for acceptable programs.]

Manuscript number:First author ________________________________________Correspondingauthor (if different from first author):Telephone/FAXnumbers:___________________________

This form (both sides) may be reproduced.

PUblished by

theAssoc1ahbo@'for

sear@cancerRe

SCOPE A DISTiNGUISHEDEDITORIALBOARD

Cell Growth &Differentiation (CG&D)

publishes significant, original research on

themolecularbiologyofcancer.Itsscopeencompasses in vitm and in vivo studies

pertainingto normal and abnormal cellular

processes.Topicsindude oncogenesand tumor

suppressor genes, gene expression and regula

tion, transcription factors, growth factors and

theirreceptors,molecularmechanismsoftumor progression, signal transduction, cell

cycle, differentiation, and development.

CG&D'sdistinguished, international Editorial

Boardhas recentlybeenexpandedtocoverthisbroadrangeofsubjectsevenmorecomprehensively.

In addition to original investigations, CG&D's

format includes Research Capsules which

summarizeandupdaterapidlychangingconcepts in the field and a Viewpointssection

for signed and anonymous write-in discussion

ofpublished articles.

INVITATiONTOAUTHORS

Send manuscripts to EditorialBoard

member ofyour choice. For details about

manuscript submission, contact:

Dr.Geo@F.VandeWoude,Editor-in-Chief301-846-1302,FAX3O1-696-1549,ortheAmericanAssociationforCancerResearch215-440-9300,FAX215-440-9355.

. Average peer reviewtime--2-3 weeks.

. Average time from acceptance to

publication--lO weeks.

. Indexed by ChemicalAbsfracts, Current

Contents, IndexMedicus, MEDLINE,

CancerLit, and BIOSIS Previews.

George F. Vande Woude

Edilor-in-Chief

MaiianoBarbacidMan Bernstein

MargaretE.BuckinghamWebster K.Cavenee

Jonathan Cooper

Suzanne Cory

SaraA.CourtneidgeTom Curran

François Cuzin

RobertEisenmanRaymond L. Erikson

MichaelM.GottesmanPeter Gruss

Nancy A.Jenkins

ORDER TODAY!

Volume 5, 1994 (12 issues)

ISSN 1044-9523

Rates in US $

$180Institutional$90IndividualnonmemberAdd$20fordeliveryoutsideUSCanadiansadd7%GST

Members, American Association

forCancerResearch:Forspecialrates, call 215-440-9300.

Orderby mail, phone, or FAX:

Cell Growth &Differentiation

do Williams&Wilkins428 East Preston Street

Baltimore, MD21202-3993

1-800-638-64231-800-638-4007 in MD

FAX:410-528-8596

FrankMcCormick

AndrewP.McMahonHarold L. Moses

Joseph R. Nevins

Yasutomi Nishizuka

Eric N. Olson

Luis F. Parada

Tony Pawson

GordonG.PetersHelen M. Piwnica-Worms

Joan V. Ruderman

JosephSchlessingerJames C. Smith

Bruce M. Spiegelman

CharlesD. Stiles

Tadatsugu Taniguchi

Sampk copy upon request

Cell Growth &DifferentiationA Journal of the Molecular Biology of Cancer

THESURGERYBRANCH,NATIONALCANCERINSTITUTE,NIH,ISSEEKINGPATIENTS FOR ONGOING CLINICAL TREATMENT PROGRAMS.

PATIENTS WITH THE FOLLOWING MALIGNANCIES

ARE BEING TREATED UNDER COMBINED MODALITY OR INNOVATIVE

IMMUNOTHERAPY PROGRAMS:

. METASTATIC MELANOMA AND KIDNEY CANCER.

. STAGE II OR LOCALLY ADVANCED BREAST CANCER.

. METASTATIC COLORECTAL CANCER TO THE LIVER.

. LOCOREGIONAL GASTRIC OR PANCREATIC CANCER.

. MESOTHELIOMA, PULMONARY METASTASES,

STAGE III A, B LUNG CANCER OR ESOPHAGEAL CANCERS

. LOCALIZED 50FF TISSUE SARCOMAS

. PERITONEAL CARCINOMATOSIS.

CARE FOR ALL PATIENTS IS PROVIDED AT THE CLINICAL CENTER, NIH,

BETHESDA, MARYLAND.

FOR MORE INFORMATION ON CANCER PROGRAMS, PLEASE CALL

(301)496—1533

NJh@flONALI ( ANGER

INSTITUTE

A Public Service Announcement Courtesy ofthis Publication

AACR SPECIAL CONFERENCE IN CANCER RESEARCH

OpeningLecturesDavidBaltimoreINewYorlçNYRobed TJIanI Berkeley,CAJan@sE.Darnell,Jr.I NewYork,NY

CellCycleandTranscrIptIon- IDavidM.LivingstonI Boston,MASt.ph.n J. EII.dg. I Houston,TXRobeit N. ElsenmanI Seattle,WACarol L Prlvn I NewYork,NY

CellCycleandTranscriptIon•IIGeorgeF.Vand.WoudeI Frede@ck,MDMarkKirechner!Boston,MASteven LReed I LaJolla,CA

SignalTransductIonSystemsInfluencIngTranscriptionJoan V. Rud.rman I Boston, MAMarcMontmlnyI LaJolla.CAJeanV.J.WangI LaJolla,CASpyridon Artavanls-TsakonesI NewHaven.CT

TranscrIptionFactorsControllingCellGrowthMIchaelKarinI LaJolla,CARIchardTreismanI London,EnglandMIchaelZ.GllmanI ColdSpnngsHarbor,NY

TranscriptionFactorsControllIngCellDifferentiation- IBrucePASplegelmanI Boston,MAElaIneV.FuchsI Chicago,ILMichaelC. RosenfeldI LaJolla,CAMichaelLevineI LaJ@ CA

TranscrIptionFactorsControllIngCeODifferentiation•IIEric N.Olson I Houston,TXStuartOrklnI Boston,MACharles P. Emerson I Philadelphia, PA

DevelopmentEddyM.DeRobertlsI LosAngeles,CARIchardBehrlngerI Houston,TXJanetRossantIToronto,Ontario,CanadaCliffordTablnI Boston,MA

Applicantsare encouragedto submitabstractsforposterpresentation.

Information and Application Forms

AmericanAssociationfor CancerResearchPublicLedgerBuilding620 Chestnut Street, Suite 816Philadelphia,PA 19106(215) 440-9300 (215) 440-9313 (FAX)ApplicatIonDeadline:June27,1994

TranscriptionalControlofCellGrowthandDifferentiation

October16-20,1994ChathamBarsInn,Chatham(CapeCod),Massachusetts

CONFERENCECHAIRPERSONS

EricN.OlsonI Houston,TXBruceM.SplegelmanI Boston,MA

PROGRAMCOMMITTEE

ElaIneV.FuchsI Chicago,ILJoanV. RudermanI Boston,MA

SCIENTIFICPROGRAM

A Pubhcaton of the Amer@can Association for Cancer Research@ Co-sponsored by the American Society of Preventive Oncology

Editor-in-Chief

Pt.I@t\()(oirca

Associate Editors

\\ . RohurtFtriicc

\Vchstcr K.Caveucu

jO@ef)h F. Fr@ttlll1el1i. .@

LilullR. (‘lit!

(;iiiis C. harris

Frederick P. Li

\\ . ht1Ol1l:t@1,011(1011

‘FlioulasE. \lOOll

.@f)raIlaI11\l.i. \Ol11tlr@t

@tl11e5\@Swellhel't.

Steven R. ldllllellf)t11Ill

.@1iceS.\\ tiitteiilorc\lillli C. \ti

(:@i@icer/:/ideinialoçi'. /3lOflhiI!k('I@V&

@ 1)t11)11S11(Soriginal rcscarcli Oil

CdilCC@C@fll@dtiOil@Lil(lPr(\(1lti@il ill Ilt1ill@tilS.

thu foIIo@@log tO1)iC@@LI(Of @I)(CitIiiltcicst:

(lCSCflj)tIVC.ailal\tiCaI. I)U)CllCilliCaI@til(l

illoiccillar@ : tllc USCof l)ioilla.rkcrs

to studs tllc IlCOI)I@LStiC@Lil(lPr11l@@PIastic

P!@C@SS(Sill IuIill@Lils:chcilloprc\ ciltioll @1il(l

OthC! t\@ of )iC\ (iltR)fl trials: @til(ltllC rOtC

of l)CIl@L\ioi@tIfactors ill CaI1CCI(tiOIOg\aIl(l

t)rC\ CfltR)il.

l@titictiIai @tttCIltU)ilC @I\Cil to tlit i(lCiltifiC@t—

10)11of factors @LSSOChLtCd@vithvarious @tSt)CCts

of tllu carcinogenic @r@ciss.iilCItldiilggcnctic

StIS('(1)tiI)iIit\@ tU)St factors. iIlfCCtU)tIS @tg(IltS.

CtlCilliCdI @Lil(lj)tl\ Si('dI carcinogens. cin'iron

illCilt@LICOilt@Lilliil@tilt@.(lictdr\ COillf)OIlCiltS

@LIl(lI)C11d\ioi@Ifactors @ticlias tOb@LCC()usc

@1Il(lStill (\P@stlr@.

Signitic@tot.( ligi oat rc@carcIluicctillg thu

IligliusI sciciititic st@Lll(Ltl(1sis iu@itud for

@.,1l1)111ISSIOI1.

For 111)11illf()lIUItR)li.COllt@LCt: l)i. PCLI\()

(;@r@@t.l@titor—iu—Ctlicf(SO-i) 52@)—2@@@.

l:.@x(@)@)@

R@tpklrc@ic@t)r@C@@51\P((titC(l h\I:@x

Pl( )ll1Pt )ti 1)1iCttU)l1 of @icccptcdf)@Lf)l@

IllilC\C(l f)\ (‘hem/cal@ l/)ctraCI.c.(‘,,r,v,it

(‘wiIe@its(@lI. I1l(1t@\•JIUIkhIS@,@tll(t.@lEI)Jt\L

\OItllllC 3, 199-i (S issues)

ISS\ lO@-996S

Ratus iu t:s S

SI @Slustitutiotial@ Ill(li\ (that 11011I11CI1l1)Cr

@(l(lS2()forde1iver@otitsidcES(:Llladlaus ad(I 7 GS'l'

\lculhcrs. .\iiicricau .@ssOCiatiOll

for (;@tI1c(@rResearch (:@@CR)ald

.@ll1crical1Societ\ of Prcvcllti\ 1

Oucolog\ (ASPO) : (olltacl \ our

sOCiCt\ for sPecial rates.

Ordur I)\ ulail. Pll@ll@.01 F.\@\:

(aiieei l;/ideiniaIo@ç;y.

l@ioiiui,kei@c&Preientioii

(@ 0 \\ iIIi@t1ll5& \\ilkiiis

-t25 EastPrestonStreet

Raltullore, \lI) 21202-3993

I-@00-638-6@i23

I—@00-63@—400@'ill \lI)

1@\:-@l0-528-SS9( Sample copy upon request

8 ISSUES IN 1994(previously 6 issues/year)

. More up-to-the-minute

informationthaneverbefore.

S Contains original research,invited editorials, selectedreviews,meeting reports,shortcommunications, AACR and

ASPOnews.

. March issue includes

abstracts from ASPO meeting.